Correlation Between CervoMed and Tscan Therapeutics

Can any of the company-specific risk be diversified away by investing in both CervoMed and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CervoMed and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CervoMed and Tscan Therapeutics, you can compare the effects of market volatilities on CervoMed and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CervoMed with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CervoMed and Tscan Therapeutics.

Diversification Opportunities for CervoMed and Tscan Therapeutics

-0.32

Correlation Coefficient

CervoMed  Tscan Therapeutics

Very good diversification

The 3 months correlation between CervoMed and Tscan is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding CervoMed and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and CervoMed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CervoMed are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of CervoMed i.e., CervoMed and Tscan Therapeutics go up and down completely randomly.

Pair Corralation between CervoMed and Tscan Therapeutics

Given the investment horizon of 90 days CervoMed is expected to generate 0.55 times more return on investment than Tscan Therapeutics. However, CervoMed is 1.8 times less risky than Tscan Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.06 per unit of risk. If you would invest  854.00  in CervoMed on September 13, 2025 and sell it today you would lose (35.00) from holding CervoMed or give up 4.1% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

CervoMed  vs.  Tscan Therapeutics

CervoMed

Risk-Adjusted Performance

Weakest

Over the last 90 days CervoMed has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, CervoMed is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Tscan Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with CervoMed and Tscan Therapeutics

The main advantage of trading using opposite CervoMed and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CervoMed position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.

The idea behind CervoMed and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.